Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients
Por:
Ferreiro-Iglesias R, Piqueras M, Ricart E, Robles LS, Andreu MR, Martín-de-Carpi J, Bentitez O, Zabana Y, Mañosa M, Moranta FR and de Acosta MB
Publicada:
1 dic 2022
Ahead of Print:
1 nov 2022
Resumen:
Patients with inflammatory bowel disease (IBD) may require different immunosuppressive treatments throughout their illness. It is essential to assess the immunization status of patients at diagnosis or, if this is not possible, at least before the beginning of immunosuppressive therapy and, subsequently, administering the appropriate vaccines.
Therefore, the aim of this work is to establish clear and concise recommendations on vaccination in patients with IBD in the different settings of our clinical practice including vaccination in children, during pregnancy, breastfeeding or on trips. This consensus document emphasises the differences between inactivated and attenuated vaccines and the different degrees of immunosuppression and correlates them with the administration of both mandatory and optional vaccines recommended to our patients with IBD. Finally, as a summary, 17 recommendations are established based on the available scientific evidence and expert opinion. A multidisciplinary team with extensive experience in IBD and vaccination, made up of specialists in gastroenterology, paediatrics, nursing and pharmacy, has participated in the preparation of these recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis. (C) 2022 The Authors. Published by Elsevier Espana, S.L.U.
Filiaciones:
Ferreiro-Iglesias R:
Servicio de Gastroenterología. Hospital Clínico Universitario de Santiago, Spain
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Spain
Piqueras M:
Servicio de Gastroenterología. Consorci Sanitari de Terrassa (CST), Spain
Ricart E:
Servicio de Gastroenterología. Hospital Clínic, IDIBAPS, Barcelona, Spain
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Robles LS:
Servicio de Gastroenterología. Hospital General Universitario de Alicante, Spain
Andreu MR:
Servicio de Farmacia. Consorci Sanitari de Terrassa (CST). Responsable del Servicio de gestión integral de vacunas (SEGIV), Spain
Martín-de-Carpi J:
Unidad para el Cuidado integral de la Enfermedad Inflamatoria Intestinal pediátrica (UCIEII-P). Servicio de Gastroenterología, Hepatología y Nutrición Pediátrica. Hospital Sant Joan de Déu (Barcelona), Spain
Bentitez O:
Servicio de Gastroenterología, Unidad de Enfermedad Inflamatoria Intestinal. Hospital Mútua de Terrassa (HMT), Spain
Zabana Y:
Servicio de Gastroenterología, Unidad de Enfermedad Inflamatoria Intestinal. Hospital Mútua de Terrassa (HMT), Spain
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Mañosa M:
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Servicio de Gastroenterología, Unidad de Enfermedad Inflamatoria Intestinal. Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Moranta FR:
Servicio de Gastroenterología, Unidad de Enfermedad Inflamatoria Intestinal. Hospital Universitario de Bellvitge, Spain
de Acosta MB:
Servicio de Gastroenterología. Hospital Clínico Universitario de Santiago, Spain
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Spain
Servicio de Gastroenterologia, Hospital Clinico Universitario de Santiago, Santiago de Compostela, A Coruna, Espana; Fundacion Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, A Coruna, Espana.; Servicio de Gastroenterologia, Consorci Sanitari de Terrassa (CST), Terrassa, Barcelona, Espana.
Green Submitted, hybrid
|